#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3230952	P	Aqueous solubility of the compound at pH 7		13		small-molecule physicochemical format	Scientific Literature
2.	ALA3230953	P	Pentanol-water partition coefficient, log P of the compound		11		small-molecule physicochemical format	Scientific Literature
3.	ALA3231023	A	Activity of calf mucosal adenosine deaminase assessed as enzyme-mediated drug metabolism by liquid chromatographic analysis	Bos taurus	13		single protein format	Scientific Literature
4.	ALA3231024	F	Antiviral activity against Herpes simplex virus 1 assessed as plaque reduction at 1.75 x 10'-5 M by cell-based assay relative to control	Human alphaherpesvirus 1	4		organism-based format	Scientific Literature
5.	ALA3231025	F	Antiviral activity against Herpes simplex virus 1 assessed as plaque reduction at 0.18 x 10'-5 M by cell-based assay relative to control	Human alphaherpesvirus 1	5		organism-based format	Scientific Literature
6.	ALA3231338	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as prevention of vaginal discharge at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	2		organism-based format	Scientific Literature
7.	ALA3231339	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as cured animal at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	1		organism-based format	Scientific Literature
8.	ALA3231341	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as prevention of inflammation at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	2		organism-based format	Scientific Literature
9.	ALA3231343	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as prevention of vesiculation of labia and vulva at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	2		organism-based format	Scientific Literature
10.	ALA3231346	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as prevention of vulvo-vaginal swelling at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	2		organism-based format	Scientific Literature
11.	ALA3231347	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as prevention of paralysis at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	2		organism-based format	Scientific Literature
12.	ALA3231420	F	Antiviral activity against Herpes simplex virus 2 Magill infected in guinea pig assessed as prevention of death at 3% compound concentration treated intravaginally bid for 4 days measured on day 16 post-infection	Human alphaherpesvirus 2	2		organism-based format	Scientific Literature
13.	ALA3231422	T	Toxicity in albino guinea pig assessed as occurrence of irritation at 3% compound concentration treated intravaginally bid for 4 days	Cavia porcellus	1		organism-based format	Scientific Literature
14.	ALA3231425	F	Antiviral activity against Herpes simplex virus 1 assessed as plaque reduction at 0.18 x 10'-5 M by cell-based assay relative to vidarabine	Human alphaherpesvirus 1	6		organism-based format	Scientific Literature
15.	ALA3231434	F	Antiviral activity against Herpes simplex virus 1 assessed as plaque reduction at 1.75 x 10'-5 M by cell-based assay relative to vidarabine	Human alphaherpesvirus 1	4		organism-based format	Scientific Literature